INFORMATION
Determination of free therapeutic golimumab
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Golimumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free golimumab in plasma or serum samples. Not all patients respond equally to golimumab, and this test helps to stratify patients according to whether they are likely to benefit from treatment or not, allowing clinicians to evaluate the drug efficacy and investigate primary non-response and loss of response.
Please contact us for your nearest test reference laboratory.
KEY ADVANTAGES
-
Highly specific quantification of golimumab, with no cross reaction with compounds of a similar structure
-
Total incubation time 130 minutes
-
Saves costs by predicting efficacy of golimumab treatment and stratifying patients accordingly
-
Applicable to both gastroenterology and rheumatology
-
Reportable range 0.36-22.5 ug/ml
-
Automatable on ELISA automates (e.g. Dynex DS2)
